Australia's most trusted
source of pharma news
Posted 19 May 2022 AM
Novartis Australia has won a global award for a digital ecosystem that improves patient adherence to prescribed medication and complex treatment regimes.
The MSGo patient support program and technology platform to support patients starting a new treatment for multiple sclerosis won the Best Compliance Solution for the 2022 Medtech Breakthrough Awards. Novartis engaged RxMx to develop the digital solution.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.